Tagged with Pharma

Bulgaria Nikolaos Xydias, general manager at GSK Bulgaria, explains the commitment of GSK to cutting-edge medicines and vaccines targeting respiratory diseases and HIV and highlights the reasons why pharmaceutical multinationals should put Bulgaria on their business map. This is your first time as a country manager. How did you prepare yourself…

Poland Zszisław Sabiłło, president of the Polish Association of the Pharmaceutical Industry Employers (PZPPF), discusses the significance of the Polish generics market in terms of volume and sales market share, and highlights the obstacles that the generics ecosystem faces in light of the new reimbursement act. Furthermore, he provides insights into…

Tunisia Walid Chriaa, CEO of SIPHAT, explains the history of the public company’s position in Tunisia, as the pearl of the Tunisian pharmaceutical industry. He also points out a few of the strategies in place to counter the financial struggles that SIPHAT has been under, such as reforms with a 2030…

Bulgaria Nikolay Hadjidontchev, general manager at Actavis EAD – a Teva company (the sales and marketing part of the company) in Bulgaria, explains the importance of finding the right balance between innovative and generic portfolios and highlights the unique positioning of Teva in Bulgaria as a consequence of the global acquisition…

Tunisia Lasaâd Boujbel, CEO of MédiS Group, and founder of the company, today leads what became one of the first Tunisian-based multinationals. His company’s recent investments in the Tunisian headquarters and in Senegal respectively respond to increased international demand and desires of expansion in the African market. MédiS has built up…

Tunisia Khalil Ben Ammar, managing director of Adwya since 2016, has been responsible for stabilizing the finances and corporate atmosphere within the company. In this interview he elaborates on the company’s leading position in the Tunisian market, its transformative environment and the exciting development plans aimed at Africa that Adwya is…

Bulgaria Dr. Hristo Trunchev, country president at Novartis Bulgaria and president of the Association of Research-Based Pharmaceutical Manufacturers in Bulgaria (ARPharM), shares an overview of the business scenario for research-based pharmaceutical players in Bulgaria and explains the role of Novartis in bringing added-value medicines to the patients. A lot has been…

Bulgaria Metodija Chadikovski, general manager at Roche Bulgaria, explains the importance of conducting high quality diagnostics to successfully target the right drug to the right patient as well as the affiliate’s commitment to developing the solutions that Bulgarian patients will need next. Could you please introduce yourself as well as your…

Tunisia Ramzi Sandi, general manager of the Arab Society of Pharmaceutical Industries (SAIPH) is responsible for the development of the company since 2015. From that date, SAIPH has been the strongest performing actor in the Tunisian market with an annual growth of 20 percent in 2016 and 2017. In this interview…

Canada Brian Hilberdink, President of Novo Nordisk Canada, highlights the key role that Canada plays as a pilot market for exporting best practices globally, the focus that Novo Nordisk is placing on the undertreated condition of obesity in Canada, and the challenges and opportunities of running an innovative pharma business in…

Canada Claude Castonguay, former Minister of Health and Social Alliance of Québec, Canada, regarded as one of the founding fathers of Québec’s healthcare system, discusses his achievements within the healthcare space, his thoughts on the current healthcare reforms under way in Québec, and his conviction of the benefits of decentralization for…

Tunisia Sara Masmoudi, general manager at Teriak, one of Tunisia’s top three pharmaceutical companies, sums up the evolution the company has undergone since she took over its direction in 2003 at age 32. She also talks about the recent acquisition Teriak has made of Cinpharm, a Cameroonian manufacturer, in line with…